Afuco™ Anti-Human SEMA4D ADCC Therapeutic Antibody (VX15/2503), ADCC Enhanced
Anti-SEMA4D ADCC Enhanced Antibody (VX15/2503) is an ADCC enhanced antibody produced by our Afuco™ platform. VX15/2503 is a novel monoclonal antibody that blocks the activity of SEMA4D. Preclinical testing has demonstrated beneficial effects of anti-SEMA4D treatment in a variety of neurodegenerative disease models. VX15/2503 was well tolerated and no Maximum Tolerated Dose (MTD) was reached.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-537CL |
| Pricing | Inquiry |
| Host | Humanized |
| Target | SEMA4D |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | Short term: store at 4°C (over 6 months), long term: -20°C or -80°C. |